Provokations-Test Lepidoglyphus destructor

Provokations-Test Lepidoglyphus destructor is a medicine authorised by Swissmedic under authorisation number 61615. The authorisation holder is Dermapharm AG. The medicinal product code is Allergen: diagnostic and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 08 November 2010 and the authorisation is valid without a time limit. The export lists no ATC code for this medicine.

  • Dispensing category A
  • Authorisation number 61615
  • Allergen: diagnostic
Authorisation data
Authorisation number61615
NameProvokations-Test Lepidoglyphus destructor
Full nameProvokations-Test Lepidoglyphus destructor, Pulver und Lösungsmittel zur Herstellung einer Provokationstestlösung
Authorisation holderDermapharm AG
Medicinal product codeAllergen: diagnostic
Dispensing categoryA · Prescription, not repeatable
ATC codenot stated
First authorisation08 November 2010
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Provokations-Test Lepidoglyphus destructor, Pulver und Lösungsmittel zur Herstellung einer ProvokationstestlösungA08 November 2010

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
The Swissmedic export lists no pack sizes for this medicine.

Scroll the table sideways

Other medicines from this authorisation holder

Frequently asked questions

Is Provokations-Test Lepidoglyphus destructor authorised in Switzerland?

Yes. Provokations-Test Lepidoglyphus destructor is authorised by Swissmedic under authorisation number 61615, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Provokations-Test Lepidoglyphus destructor have?

Provokations-Test Lepidoglyphus destructor is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.

Who is the authorisation holder of Provokations-Test Lepidoglyphus destructor?

The authorisation holder is Dermapharm AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com